Literature DB >> 23843110

The COPCORD world of musculoskeletal pain and arthritis.

Arvind Chopra1.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23843110     DOI： 10.1093/rheumatology/ket222

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  23 in total

1.  Brazilian urban population norms derived from the health-related quality of life SF-6D.

Authors:  Rozana Mesquita Ciconelli; Marcos Bosi Ferraz; Sérgio Kowalski; Geraldo da Rocha Castelar Pinheiro; Emilia Inoue Sato
Journal:  Qual Life Res       Date:  2015-04-18       Impact factor: 4.147

2.  Overcoming challenges in order to improve the management of rheumatic and musculoskeletal diseases across the globe.

Authors:  Anthony D Woolf; Sherine Gabriel
Journal:  Clin Rheumatol       Date:  2015-02-21       Impact factor: 2.980

3.  Prevalence of musculoskeletal diseases in a semi-urban Nigerian community: results of a cross-sectional survey using COPCORD methodology.

Authors:  Uhunmwangho U Courage; Dungwom P Stephen; Imoh C Lucius; Charles Ani; Agbaji O Oche; Agaba I Emmanuel; Adelowo O Olufemi
Journal:  Clin Rheumatol       Date:  2017-04-26       Impact factor: 2.980

4.  We must harness technology to deliver the musculoskeletal disease epidemiology that is urgently needed across sub-Saharan Africa.

Authors:  Doug L Fink; David Oladele; Oseme Etomi; Hakeem Olaosebikan; Ida Dzifa Dey; Olufemi Olawale Adelowo
Journal:  Clin Rheumatol       Date:  2018-02-08       Impact factor: 2.980

5.  Rheumatoid arthritis in the indigenous qom population of Rosario, Argentina: aggressive and disabling disease with inadequate adherence to treatment in a community-based cohort study.

Authors:  Rosana Quintana; Mario Goñi; Nora Mathern; Marisa Jorfen; Silvana Conti; Romina Nieto; Alvaro Sanabria; Cristina Prigione; Adriana M R Silvestre; Vanina García; Guillermo Pons-Estel; Ricard Cervera; Conrado García; Ingris Peláez-Ballestas; Graciela S Alarcón; Bernardo A Pons-Estel
Journal:  Clin Rheumatol       Date:  2018-04-19       Impact factor: 2.980

6.  Itolizumab in combination with methotrexate modulates active rheumatoid arthritis: safety and efficacy from a phase 2, randomized, open-label, parallel-group, dose-ranging study.

Authors:  Arvind Chopra; S Chandrashekara; Rajgopalan Iyer; Liza Rajasekhar; Naresh Shetty; Sarathchandra Mouli Veeravalli; Alakendu Ghosh; Mrugank Merchant; Jyotsna Oak; Vikram Londhey; Abhijit Barve; M S Ramakrishnan; Enrique Montero
Journal:  Clin Rheumatol       Date:  2015-06-07       Impact factor: 2.980

7.  WHO-ILAR COPCORD study (stage 1, urban study) in Sanandaj, Iran.

Authors:  Nasrin Moghimi; Fereydoun Davatchi; Ezat Rahimi; Afshin Saidi; Naser Rashadmanesh; Solmaz Moghimi; Hoshyar Ghafori; Peiman Zandi; Negin Ahmadi; Hamed Ghafori; Mohsen Moghimi; Marjan hajiheshmati
Journal:  Clin Rheumatol       Date:  2013-11-09       Impact factor: 2.980

Review 8.  Small molecules of herbal origin for osteoarthritis treatment: in vitro and in vivo evidence.

Authors:  Penghui Zhang; Kaihu Li; Amir Kamali; Reihane Ziadlou; Paras Ahmad; Xinluan Wang; R Geoff Richards; Mauro Alini; Valentina Basoli; Zhen Li; Sibylle Grad
Journal:  Arthritis Res Ther       Date:  2022-05-11       Impact factor: 5.606

Review 9.  The global challenges and opportunities in the practice of rheumatology: white paper by the World Forum on Rheumatic and Musculoskeletal Diseases.

Authors:  Mustafa Al Maini; Femi Adelowo; Jamal Al Saleh; Yousef Al Weshahi; Gerd-Rüdiger Burmester; Maurizio Cutolo; Joseph Flood; Lyn March; Heather McDonald-Blumer; Kevin Pile; Carlos Pineda; Carter Thorne; Tore K Kvien
Journal:  Clin Rheumatol       Date:  2014-12-14       Impact factor: 2.980

10.  The burden of musculoskeletal conditions.

Authors:  Clémence Palazzo; Jean-François Ravaud; Agathe Papelard; Philippe Ravaud; Serge Poiraudeau
Journal:  PLoS One       Date:  2014-03-04       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.